AO mRNA-LNP Stabilization

Invention type: Technology / Case number: #26266
License tlo.mit.edu/contact-us

Researchers

Ana Jaklenec / Robert Langer / Linzixuan Rhoda Zhang / Jooli Han / Tina Huang

Departments: David H Koch Institute for Integrative Cancer Res, Office of the Institute Professors, Chemical Engineering
Technology Areas: Biotechnology: DNA & RNA Editing / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living

  • stabilization of mrna-lnps with antioxidants
    United States of America | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Contact Us

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

Sign Up

More Technologies

Innate Immune Modulating RNA Vaccines

#26293H
B.j. Kim / Darrell J Irvine
Therapeutics

Synergisms between Small Molecule Boosters and LNP Formulations Uncovered using High Throughput Screening and Machine Learning

#26199J
Giovanni Traverso / Ameya Kirtane / Rajib Dey / Deepak Subramanian
Artificial Intelligence (AI) and Machine Learning (ML) / Computer Science / Drug Delivery / Therapeutics

Lipid-Polymer Microparticles (mLPM) For Thermostable, Pulsatile mRNA-LNP Vaccines

#26154
Ana Jaklenec / Robert Langer / Linzixuan Rhoda Zhang / Yuting Huang
Drug Delivery / Therapeutics